| General Medical Therapies and Clinical Treatment Research | Lifetime | 3 | PT 1 | 99.40 |
| Cerebrospinal fluid and hydrocephalus | Lifetime | 211 | PT 2 | 98.08 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 340 | PT 2 | 98.05 |
| Pain Mechanisms and Treatments | Lifetime | 456 | PT 1 | 97.96 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 710 | PT 1 | 98.09 |
| Facial Nerve Paralysis Treatment and Research | Lifetime | 145 | PT 1 | 97.39 |
| Pain Management and Treatment | Lifetime | 133 | PT 1 | 97.18 |
| Meningioma and schwannoma management | Lifetime | 483 | PT 1 | 97.48 |
| Musculoskeletal pain and rehabilitation | Lifetime | 928 | PT 2 | 97.52 |
| Trigeminal Neuralgia and Treatments | Lifetime | 141 | PT 1 | 97.23 |
| Neurosurgical Procedures and Complications | Lifetime | 334 | PT 3 | 97.00 |
| Pain Management and Opioid Use | Lifetime | 288 | PT 1 | 97.01 |
| Nerve Injury and Rehabilitation | Lifetime | 371 | PT 1 | 96.56 |
| Myofascial pain diagnosis and treatment | Lifetime | 284 | PT 2 | 95.34 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 579 | PT 2 | 95.79 |
| Pediatric Pain Management Techniques | Lifetime | 515 | PT 3 | 94.77 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 854 | PT 2 | 95.05 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 730 | PT 2 | 93.56 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 957 | PT 3 | 93.26 |
| Temporomandibular Joint Disorders | Lifetime | 798 | PT 3 | 94.02 |
| Pain Management and Placebo Effect | Lifetime | 608 | PT 1 | 92.71 |
| Spinal Dysraphism and Malformations | Lifetime | 794 | PT 2 | 90.40 |
| Spinal Hematomas and Complications | Lifetime | 625 | PT 1 | 86.07 |
| Oropharyngeal Anatomy and Pathologies | Lifetime | 326 | PT 2 | 84.44 |
| Intraoperative Neuromonitoring and Anesthetic Effects | Lifetime | 503 | PT 1 | 83.77 |
| Pain Mechanisms and Treatments | 2021-2025 | 509 | PT 2 | 87.74 |
| Meningioma and schwannoma management | 2021-2025 | 603 | PT 1 | 88.35 |
| Cerebrospinal fluid and hydrocephalus | 2021-2025 | 539 | PT 2 | 84.99 |
| Intracranial Aneurysms: Treatment and Complications | 2021-2025 | 989 | PT 3 | 86.32 |
| Neurosurgical Procedures and Complications | 2021-2025 | 464 | PT 1 | 82.95 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 753 | PT 5 | 81.34 |
| Pain Management and Treatment | 2021-2025 | 578 | PT 3 | 71.82 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 955 | PT 2 | 68.51 |
| Cerebral Venous Sinus Thrombosis | 2021-2025 | 913 | PT 10 | 67.28 |
| Intraoperative Neuromonitoring and Anesthetic Effects | 2021-2025 | 342 | PT 1 | 54.33 |
